143 related articles for article (PubMed ID: 36513602)
21. Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma.
Afrough A; Alsfeld LC; Milton DR; Delgado R; Popat UR; Nieto Y; Kebriaei P; Oran B; Saini N; Srour S; Hosing C; Cheema FH; Ahmed S; Manasanch EE; Lee HC; Kaufman GP; Patel KK; Weber DM; Orlowski RZ; Pinnix CC; Dabaja BS; Thomas SK; Champlin RE; Shpall EJ; Qazilbash MH; Bashir Q
Transplant Cell Ther; 2023 Apr; 29(4):264.e1-264.e9. PubMed ID: 35605883
[TBL] [Abstract][Full Text] [Related]
22. Outcome of allogeneic hematopoietic cell transplantation in patients with adult T-cell leukemia.
Kamiunten A; Sekine M; Kameda T; Akizuki K; Tahira Y; Shide K; Shimoda H; Kato K; Hidaka T; Kubuki Y; Shimoda K
Hematol Oncol; 2018 Oct; 36(4):651-655. PubMed ID: 30117169
[TBL] [Abstract][Full Text] [Related]
23. Allogeneic hematopoietic stem cell transplantation after mogamulizumab in T-cell lymphoma patients: a retrospective analysis.
Lechowicz MJ; Smith C; Ristuccia R; Dwyer K
Int J Hematol; 2024 Jun; 119(6):736-744. PubMed ID: 38532079
[TBL] [Abstract][Full Text] [Related]
24. Factors that contribute to long-term survival in patients with leukemia not in remission at allogeneic hematopoietic cell transplantation.
Koh H; Nakamae H; Hagihara K; Nakane T; Manabe M; Hayashi Y; Nishimoto M; Umemoto Y; Nakamae M; Hirose A; Inoue E; Inoue A; Yoshida M; Bingo M; Okamura H; Aimoto R; Aimoto M; Terada Y; Koh KR; Yamane T; Ohsawa M; Hino M
J Exp Clin Cancer Res; 2011 Apr; 30(1):36. PubMed ID: 21477348
[TBL] [Abstract][Full Text] [Related]
25. Prognostic importance of pretransplant disease status for posttransplant outcomes in patients with adult T cell leukemia/lymphoma.
Inoue Y; Fuji S; Tanosaki R; Inamoto Y; Tanaka T; Ito A; Okinaka K; Kurosawa S; Kim SW; Nakagama H; Fukuda T
Bone Marrow Transplant; 2018 Sep; 53(9):1105-1115. PubMed ID: 29523883
[TBL] [Abstract][Full Text] [Related]
26. PD-1 blockade for relapsed lymphoma post-allogeneic hematopoietic cell transplant: high response rate but frequent GVHD.
Haverkos BM; Abbott D; Hamadani M; Armand P; Flowers ME; Merryman R; Kamdar M; Kanate AS; Saad A; Mehta A; Ganguly S; Fenske TS; Hari P; Lowsky R; Andritsos L; Jagasia M; Bashey A; Brown S; Bachanova V; Stephens D; Mineishi S; Nakamura R; Chen YB; Blazar BR; Gutman J; Devine SM
Blood; 2017 Jul; 130(2):221-228. PubMed ID: 28468799
[TBL] [Abstract][Full Text] [Related]
27. Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational study.
Ito A; Nakano N; Tanaka T; Fuji S; Makiyama J; Inoue Y; Choi I; Nakamae H; Nagafuji K; Takase K; Machida S; Takahashi T; Sawayama Y; Kamimura T; Kato K; Kawakita T; Ogata M; Sakai R; Shiratori S; Uchimaru K; Inamoto Y; Utsunomiya A; Fukuda T
Blood Adv; 2021 Oct; 5(20):4156-4166. PubMed ID: 34500464
[TBL] [Abstract][Full Text] [Related]
28. [Treatment approach for relapse of adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation].
Kato K
Rinsho Ketsueki; 2021; 62(5):505-511. PubMed ID: 34248128
[TBL] [Abstract][Full Text] [Related]
29. Clinical Impact of a Humanized CCR4 Antibody (Mogamulizumab) in 14 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated at a Single Institution During a Three-year Period (2012-2014).
Kawano N; Kuriyama T; Sonoda KH; Yoshida S; Yamashita K; Ochiai H; Shimoda K; Ishikawa F; Ueda A; Kikuchi I
Intern Med; 2016; 55(11):1439-45. PubMed ID: 27250049
[TBL] [Abstract][Full Text] [Related]
30. Allogeneic hematopoietic stem cell transplantation for ATL with central nervous system involvement: the Nagasaki transplant group experience.
Fukushima T; Taguchi J; Moriuchi Y; Yoshida S; Itonaga H; Ando K; Sawayama Y; Imaizumi Y; Imanishi D; Hata T; Miyazaki Y
Int J Hematol; 2011 Oct; 94(4):390-394. PubMed ID: 21960057
[TBL] [Abstract][Full Text] [Related]
31. Treatment of relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: the Nagasaki Transplant Group experience.
Itonaga H; Tsushima H; Taguchi J; Fukushima T; Taniguchi H; Sato S; Ando K; Sawayama Y; Matsuo E; Yamasaki R; Onimaru Y; Imanishi D; Imaizumi Y; Yoshida S; Hata T; Moriuchi Y; Uike N; Miyazaki Y
Blood; 2013 Jan; 121(1):219-25. PubMed ID: 23100309
[TBL] [Abstract][Full Text] [Related]
32. Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation.
Utsunomiya A; Miyazaki Y; Takatsuka Y; Hanada S; Uozumi K; Yashiki S; Tara M; Kawano F; Saburi Y; Kikuchi H; Hara M; Sao H; Morishima Y; Kodera Y; Sonoda S; Tomonaga M
Bone Marrow Transplant; 2001 Jan; 27(1):15-20. PubMed ID: 11244433
[TBL] [Abstract][Full Text] [Related]
33. Multicenter Phase II Study of Lenalidomide in Relapsed or Recurrent Adult T-Cell Leukemia/Lymphoma: ATLL-002.
Ishida T; Fujiwara H; Nosaka K; Taira N; Abe Y; Imaizumi Y; Moriuchi Y; Jo T; Ishizawa K; Tobinai K; Tsukasaki K; Ito S; Yoshimitsu M; Otsuka M; Ogura M; Midorikawa S; Ruiz W; Ohtsu T
J Clin Oncol; 2016 Dec; 34(34):4086-4093. PubMed ID: 27621400
[TBL] [Abstract][Full Text] [Related]
34. Survival of Lymphoma Patients Experiencing Relapse or Progression after an Allogeneic Hematopoietic Cell Transplantation.
Epperla N; Hamadani M; Ahn KW; He F; Kodali D; Kleman A; Hari PN; Pasquini M; Fenske TS; Craig MD; Kanate AS; Bachanova V
Biol Blood Marrow Transplant; 2018 May; 24(5):983-988. PubMed ID: 29410340
[TBL] [Abstract][Full Text] [Related]
35. Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study.
Kanda J; Hishizawa M; Utsunomiya A; Taniguchi S; Eto T; Moriuchi Y; Tanosaki R; Kawano F; Miyazaki Y; Masuda M; Nagafuji K; Hara M; Takanashi M; Kai S; Atsuta Y; Suzuki R; Kawase T; Matsuo K; Nagamura-Inoue T; Kato S; Sakamaki H; Morishima Y; Okamura J; Ichinohe T; Uchiyama T
Blood; 2012 Mar; 119(9):2141-8. PubMed ID: 22234682
[TBL] [Abstract][Full Text] [Related]
36. Mogamulizumab for post-transplant relapse of adult T-cell leukemia/lymphoma: a case study.
Hirosawa M; Goto M; Oku M; Akao K; Kitamura N; Nakanishi T; Tanaka A; Niino D; Higashi T; Morimoto H; Tsukada J
Int J Hematol; 2023 Jan; 117(1):143-148. PubMed ID: 36083572
[TBL] [Abstract][Full Text] [Related]
37. GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma.
Muranushi H; Shindo T; Hishizawa M; Tokunaga M; Wake A; Nakano N; Eto T; Hidaka M; Choi I; Miyamoto T; Uchida N; Moriuchi Y; Miyazaki Y; Fukuda T; Ichinohe T; Atsuta Y; ; Kato K
Bone Marrow Transplant; 2021 Jan; 56(1):155-166. PubMed ID: 32665675
[TBL] [Abstract][Full Text] [Related]
38. Analysis of relapse after transplantation in acute leukemia: A comparative on second allogeneic hematopoietic cell transplantation and donor lymphocyte infusions.
Ortí G; Sanz J; García-Cadenas I; Sánchez-Ortega I; Alonso L; Jiménez MJ; Sisinni L; Azqueta C; Salamero O; Badell I; Ferra C; de Heredia CD; Parody R; Sanz MA; Sierra J; Piñana JL; Querol S; Valcárcel D
Exp Hematol; 2018 Jun; 62():24-32. PubMed ID: 29526774
[TBL] [Abstract][Full Text] [Related]
39. Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma.
Fuji S; Shindo T
Stem Cell Investig; 2016; 3():70. PubMed ID: 27868052
[TBL] [Abstract][Full Text] [Related]
40. [Role of anti-CCR4 antibody in the treatment of transplant-eligible patients with aggressive adult T-cell leukemia/lymphoma].
Fuji S
Rinsho Ketsueki; 2018; 59(4):426-431. PubMed ID: 29743403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
